Tuberous Sclerosis Complex-associated Refractory Seizures

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-11-07
Clinical Trial Update: A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures [Phase 3]
Phase 3 trial evaluating efficacy and safety of two trough ranges of everolimus as adjunctive therapy in tuberous sclerosis complex–associat…